Skip to main content
SpringerLink
Log in

Das kulturell-biochemische und serologische Verhalten der Cryptococcus-Gruppe

  • Conference paper
Book cover Ergebnisse der Mikrobiologie Immunitätsforschung und Experimentellen Therapie

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 32))

Zusammenfassung

Seit Entdeckung des Erregers der Cryptococcose durch Busse (24, 25, 26) und Buschke (23) vor rund 65 Jahren (7) ist diese weltweit verbreitete, durch einen Sproßpilz verursachte Krankheit annähernd 500mal beim Menschen nachgewiesen worden [vgl. (37, 42, 66, 111 u. a.)], sporadisch und epizootisch ferner beim Milchvieh sowie vereinzelt beim Affen, Schwein, Pferd, Hund, Katze, Meerschweinchen und bei anderen Tierarten [Zusammenfassung s. (61, 111)].

Aus dem Hygiene-Institut der Rheinischen Friedrich Wilhelms-Universität Bonn/Rh. (Direktor: Prof. Dr. Dr. H. Eyer).

Herrn Prof. Dr. E. Rodenwaldt zum 80. Geburtstag gewidmet.

Ein Teil der experimentellen Untersuchungen wurde mit Mitteln der Deutschen Forschungsgemeinschaft durchgeführt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ajello, L., V. Q. Grant, and M. A. Gutske: The effect of tubercle bacillus concentration procedures on fungi causing pulmonary mycosis. J. Lab. clin. Med. 38, 486–491 (1951).

    CAS  PubMed  Google Scholar 

  2. Ajello, L., V. Q. Grant, and M. A. Gutske: Soil as a natural reservoir for human pathogenic fungi. Science 123, 876–879 (1956).

    CAS  PubMed  Google Scholar 

  3. Ajello, L., Occurrence of Cryptococcus neoformans in soils. Amer. J. Hyg. 67, 72–77 (1958).

    CAS  PubMed  Google Scholar 

  4. Ajello, L., V. Q. Grant and M. A. Gutske: Use of mineral oil in the maintenance of cultures of fungi pathogenic for humans Arch. Derm. Syph. (Chicago) 63, 747–749 (1951).

    CAS  Google Scholar 

  5. Arzt, L.: Zur Klinik und Pathologie der SproBpilzerkrankungen. Arch. Derm. Syph. (Berl.) 145, 311–312 (1924).

    Google Scholar 

  6. Asohner, M., J. Mager and J. Leibowitz: Production of extracellular starch in cultures of capsulated yeasts. Nature (Lond.) 156, 295 (1945).

    Google Scholar 

  7. Asohner, M., and A. Cury: Starch production in the genus Trichosporon. J. Bact. 62, 350–352 (1952).

    Google Scholar 

  8. Ashbel, R., and A. Dolb: 60 years discovery of C. neoformans (Sanfelice) Vuillemin (Torula histolytica). Harefuah, 49, 108–113 (1955).

    CAS  PubMed  Google Scholar 

  9. Ashner, M., and D. Godinger: An ecological study of yeasts of the genus Cryptococcus. Harefuah 49, 107–108 (1955).

    CAS  PubMed  Google Scholar 

  10. Bauer, H: Mikroskopisch-chemischer Nachweis von Glykogen und einigen anderen Polysacchariden. Z. mikr -anat. Forsch. 33, 143–160 (1933).

    Google Scholar 

  11. Benham, RH.: Cryptococci–their identification by morphology and serology. J. infect. Dis. 57, 255–274 (1937).

    Google Scholar 

  12. Benham, RH.: Cryptococcosis and blastomycosis. Ann. N.Y. Acad. Sci. 50, 1199–1214 (1955).

    Google Scholar 

  13. Benham, RH.: The genus Cryptococcus: the present status and criteria for the identification of species. Trans. N.Y. Acad. Sci., Ser. II, 17, 418–429 (1955).

    CAS  Google Scholar 

  14. Benham, RH.: The genus Cryptococcus. Beet. Rev. 20, 189–196 (1956).

    CAS  Google Scholar 

  15. Benham, RH.: Cryptococcus neoformans: An ascomycete. Proc. Soc. exp. Biol. (N. Y.) 89, 243–245 (1955).

    CAS  Google Scholar 

  16. Beijerinck, M. W.: L’auxanographie, ou la méthode de l’hydrodiffusion dans la gelatine appliquée aux recherches microbiologiques. Arch. néerl. Sci. 23, 367–372 (1889).

    Google Scholar 

  17. Bieberdorf, F. W.: A study of the growth response of some fungi to various concentrations of isonicotinic acid hydrazide. Antibiot. and Chemother. (Basel) 3, 513–520 (1953).

    CAS  Google Scholar 

  18. Bocobo, F. C., A. C. Curtis, W. D. Block, E. R. Harrell, E. E. Evans, and R. F. Haines: Evaluation of nitrostyrenes as antifungal agents. Antibiot. and Chemother. (Basel) 6, 385–390 (1956).

    CAS  Google Scholar 

  19. Brian, P. W., and J. C. McGowan: Viridin: a highly fungistatic substance produced by Trichoderma viride. Nature (Lond.) 156, 144–145 (1945).

    CAS  Google Scholar 

  20. Brockmann, D. D.: The in vitro effect of atabrine on Cryptococcus neoformans. Amer. J. trop. Med. 28, 295–297 (1948).

    Google Scholar 

  21. Brown, R., and E. Hazen: Nystatin and actidione: Two antifungal agents produced by Streptomyces noursei. In Sternberg and Newcomer, Therapy of fungus diseases, p. 164–167. Boston and Toronto: Little, Brown & Comp. 1955.

    Google Scholar 

  22. Buell, C. B., and W. H. Weston: Application of the mineral oil conservation method to maintaining collection of fungus cultures. Amer. J. Bot. 34, 555–561 (1947).

    Google Scholar 

  23. Burke, R. D., J. H. Swartz, S. S. Chapman, and W. Y. Huang: Mycoticin, a new anti-fungal antibiotic. J. invest. Derm. 23, 163–168 (1957).

    Google Scholar 

  24. Buschke, A.: Über eine durch Coccidien hervorgerufene Krankheit des Menschen. Dtsch. med. Wschr. 1895, 14.

    Google Scholar 

  25. Busse, O.: Über parasitäre Zelleinschlüsse und ihre Züchtung. Zbl. Bakt., I. Abt. Orig. 16, 175–180 (1894).

    Google Scholar 

  26. Busse, O.: Über Saccharomycosis hominis. Virchows Arch. path. Anat. 140, 23–46 (1895).

    Google Scholar 

  27. Busse, O.: Experimentelle Untersuchungen über Saccharomycosis. Virchows Arch. path. Anat. 144, 360–372 (1896).

    Google Scholar 

  28. Caldwell, D. C., and S. S. Raphael: A case of cryptococcal meningitis. J. clin. Path. 8, 32–37 (1955).

    CAS  PubMed  Google Scholar 

  29. Carson, L. E., and C. C. Campbell: The inhibition effect of three antihistaminic compounds on the growth of fungi pathogenic for man. Science 111, 689–691 (1950).

    CAS  PubMed  Google Scholar 

  30. Carter, A. S., and J. L. Young: Note on the isolation of Cryptococcus neoformans from a sample of milk J Path. Beet. 62, 271 (1950).

    CAS  Google Scholar 

  31. Carvajal, F.: Fluvomycin: an antibiotic effective against pathogenic bacteria and fungi. Antibiot. and Chemother. (Basel) 3, 765–772 (1953).

    CAS  Google Scholar 

  32. Carton, C. A.: Treatment of central nervous system cryptococcosis; a review and report of four cases treated with actidione. Ann. intern. Med. 37, 123–154 (1952).

    CAS  PubMed  Google Scholar 

  33. Carton, C. A., and CH. S. Liebig: Treatment of central nervous system cryptococcosis; laboratory studies. Arch. intern. Med. 91, 773–783 (1953).

    CAS  Google Scholar 

  34. Christensen, W. B.: Urea decomposition as a means of differentiating Proteus and Paracolon cultures from each other and from Salmonella and Shigella types. J. Bact. 52, 461–466 (1946).

    CAS  PubMed  Google Scholar 

  35. Christison, J. G., N. F. Conant, and C. K. Bradsher: The sensitivity of Histoplasma capsulatum to rhodanine and related compounds. In Sternberg and Newcomer, Therapy of fungus diseases, p. 268–278. Boston and Toronto: Little, Brown & Comp. 1955.

    Google Scholar 

  36. Ciferri, R.: Studi sulli torulopsidaceae. Atti Ist. Bot. Univ. Pisa, Ser. Iii 2, 147–301 (1925).

    Google Scholar 

  37. Ciferri, R.: A neglected definition of the genus Cryptococcus made by Rivolta (1873). Mycopathologia (Den Haag) 6, 135–136 (1951).

    CAS  Google Scholar 

  38. Conant, N. F., D. T. Smith, R. D. Baker, J. L. Callaway, and D. ST. Martin: Manual of clinical mycology, 2. edit. Philadelphia and London: W. B. Saunders Company 1954.

    Google Scholar 

  39. Connell, G. H., and C. E. Skinner: The origin of some species of the genus Candida in non-pseudomycelium-producing anaskosporogenous yeasts. Mycopathologia (Den Haag) 6, 65–71 (1951).

    CAS  Google Scholar 

  40. Connell, G. H., and C. E. Skinner: The external surface of the human body as a habitat for nonfermenting non-pigmented yeasts. J. Bact. 66, 627–633 (1953).

    CAS  PubMed  Google Scholar 

  41. Connell, G. H., C. E. Skinner, and R. C. Hurd: Lipomyces starkeyi on the skin surface of the human body. Mycologia (N. Y.) 46, 12–15 (1954).

    Google Scholar 

  42. Costantin, M. J.: Sur les levures des animaux. Soc. Mycol. France 17, 145–148 (1901).

    Google Scholar 

  43. Cox, L. B., and J. C. Tolhurst: Human Torulosis, p. 149. Melbourne: University Press 1946.

    Google Scholar 

  44. Crone, J. T., A. F. de Groat and J. G. Wahlin: Torula infection. Amer. J. Path. 13, 863–879 (1937).

    CAS  Google Scholar 

  45. Ciirtis, A. C., F. C. Boeobo, E. R. Harrell, and W. D. Block: Further studies on antifungal activity on some cinnamic acid derivatives and nitrostyrenes. Arch. Derm. Syph. (Chicago) 70, 786–798 (1954).

    Google Scholar 

  46. Danowski, T. S., and M. Tager: Thiourea and the inhibition of growth by fungi. J. infect. Dis. 82, 119–125 (1948).

    CAS  PubMed  Google Scholar 

  47. Beurmann, L. DE, R. GouGerot: Les exascoses, endomycoses et parendomycoses (Muguet), saccharomycoses (mycose de Busse-Buschge) et parasaccharomycosezymonématoses (mycose Gilchrist). R.vision et démembrement de l’ancien groupe des blastomycoses. Trib. méd. Paris 42, 501–505, 517–524 (1909).

    Google Scholar 

  48. Diddens, H. A., u. J. Lodder: Die anaskosporogenen Hefen, 2. Hälfte. Amsterdam: Noord-Hollandsche Uitgevers Mantschappij 1942.

    Google Scholar 

  49. Dimenna, M. E.: Cryptococcus terreus n. sp., from soil in New Zealand J gen. Microbiol. 11, 195–197 (1954).

    CAS  PubMed  Google Scholar 

  50. Dodge, C. W.: Medical mycology. St. Louis: C. V. Mosby Comp. 1935.

    Google Scholar 

  51. Drake, C. H.: Antigenicity of Cryptococcus neoformans. Soc. Amer. Bact., Proc. 1948, p. 57.

    Google Scholar 

  52. Drouhet, E., et G. Segretain: Sur l’action de la lactoflavine â l’égard de Torulopsis histolytica (T. neoformans) et d’autres champignons pathogènes. C. R. Soc. Biol. (Paris) 142, 316–318 (1948).

    CAS  Google Scholar 

  53. Drouhet, E., et G. Segretain: Action de hyaluronidase sur la capsule de Torula histolytica. C. R. Acad. Sci. (Paris) 228, 424–425 (1949).

    CAS  Google Scholar 

  54. Drouhet, E., et G. Segretain: Biologie et pouvoir pathogène de torulopsis neoformans (Torula histolytica). Rev. Path. comp. 50, 37–43 (1950).

    CAS  Google Scholar 

  55. Drouhet, E., G. Segretain, et J. P. Aubert: Polyoside capsulaire d’un champignon pathogène Torulopsis neoformans. Relation avec la virulence. Ann. Inst. Pasteur 79, 891–900 (1950).

    CAS  Google Scholar 

  56. Drouhet, E., et M. Couteau: Sur les variations sectorielles des colonies de Torulopsis neoformans. Ann. Inst. Pasteur 80, 456–457 (1951).

    CAS  Google Scholar 

  57. Drouhet, E., et G. Segretain: Actions réciproques entre phagocytes et Torulopsis neoformans. Bull. sci. roum. Sect. Sci. méd. 1, 40–44 (1952).

    Google Scholar 

  58. Einbinder, J. M., RH. W. Benham, and C. T. Nelson: Chemical analysis of the capsular substance of Cryptococcus neoformans. J. invest. Derm. 22, 279–283 (1954).

    CAS  PubMed  Google Scholar 

  59. Emmons, Ch.: In Henrici, Molds, yeasts and actinomycetes, 2. edit. New York and London: John Wiley & Sons 1947.

    Google Scholar 

  60. Emmons, Ch.: The natural occurrence in animals and soil of fungi which cause disease in man. Proc. 7. Int. Bot. Congr., Stockholm 1950, p. 416–421.

    Google Scholar 

  61. Emmons, Ch.: Isolation of Cryptococcus neoformans from soil. Bact. Proc. 2, 113 (1951).

    Google Scholar 

  62. Emmons, Ch.: Isolation of Cryptococcus neoformans from soil. J. Bact. 62, 685–690 (1951).

    CAS  PubMed  Google Scholar 

  63. Emmons, Ch.: Cryptococcus neoformans strains from severe outbreak of bovine mastitis. Mycopathologia (Den Haag) 6, 231–234 (1952).

    Google Scholar 

  64. Emmons, Ch.: The significance of saprophytism in the epidemiology of the mycoses. Trans. N. Y. Acad. Sci., Ser. II 17, 157–166 (1954).

    CAS  Google Scholar 

  65. Emmons, Ch.: Saprophytic sources of Cryptococcus neoformans associated with the pidgeon (Columbia livia). Amer. J. Hyg. 62, 227–232 (1955).

    CAS  PubMed  Google Scholar 

  66. Evans, E. E.: An immunologic comparison of twelve strains of Cryptococcus neoformans (Torula histolytica). Proc. Soc. exp. Biol. (N. Y.) 71, 644–646 (1949).

    CAS  Google Scholar 

  67. Evans, E. E.: The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular and agglutination reactions. J. Immunol. 64, 423–430 (1950).

    CAS  PubMed  Google Scholar 

  68. Evans, E. E., and J. W. Mehl: A qualitative analysis of capsular polysaccharides from Cryptococcus neoformans by filter paper chromatography. Science 114, 10–11 (1951).

    CAS  PubMed  Google Scholar 

  69. Evans, E. E., and J. F. Kessel: The antigenic composition of Cryptococcus neoformans. II. Serologic studies with the capsular polysaccharides. J. Immunol. 67, 109–114 (1951).

    CAS  PubMed  Google Scholar 

  70. Evans, E. E., and E. R. Harrell jr.: Cryptococcosis (Torulosis): A review of recent cases. Univ. Mich. med. Bull. 18, 43–63 (1952).

    CAS  PubMed  Google Scholar 

  71. Evans, E. E., and R. J. Theriault: The antigenic composition of Cryptococcus neoformans IV. The use of paper chromatography for following purification of the capsular polysaccharide. J. Bact. 65, 571–577 (1953).

    CAS  PubMed  Google Scholar 

  72. Evans, E. E., L. J. Sorensen and K. W. Walls: The antigenic composition of Cryptococcus neoformans. V. A survey of cross-reactions among strains of Cryptococcus and other antigens. J. Bact. 66, 287–293 (1953).

    CAS  PubMed  Google Scholar 

  73. Evans, E. E., and R. F Haines: The agglutination of ion exchange resin particles coated with polysaccharide. J. Bact. 68, 130–131 (1.954).

    Google Scholar 

  74. Evans, E. E., H. P R Seeliger, L. Kornfeld and C. Garcia: Failure to demonstrate capsular swelling in Cryptococcus neoformans. Proc. Soc. exp. Biol. (N. Y.) 93, 257–260 (1956).

    CAS  Google Scholar 

  75. Fischer, J B, and N. A. Labzoffsky: Preparation of complement fixing antigen from C. neoformans. C.nad. J. Microbiol. 1, 451–454 (1955).

    CAS  Google Scholar 

  76. Fisher, A. M.: The clinical picture associated with infections due to Cryptococcus neoformans (Torula histolytica). Report of three cases with some experimental studies. Bull. John Hopk. Hosp. 86, 383–414 (1950).

    CAS  Google Scholar 

  77. Florestano, H. J., and M. E. Bahler: Antifungal properties of the polymyxins. Proc. Soc. exp. Biol. (N. Y.) 79, 141–143 (1952).

    CAS  Google Scholar 

  78. Foley, G. E., and L. L. Uzman: Studies on the biology of Cryptococcus. IV. Isolation of a highly polymerized polysaccharide from encapsulated strains. J. infect. Dis. 90, 38–43 (1952).

    CAS  PubMed  Google Scholar 

  79. Freeman, W.: Torula meningo-encephalitis; comparative histopathology in seventeen cases. Trans. Amer. neurol. Ass. 203–217 (1930).

    Google Scholar 

  80. Giordano, A.: Studia micologica de Debaryomyces neoformans (Sanfelice) Redaelli, Ciferri et Giordano e significata della specie nella patologia animale. Mycopathologia (Den Haag) 1, 274–304 (1939).

    Google Scholar 

  81. Gold, W., H. A. Stout, J. F. Pagano, and R. Donovick: Amphothericins A and B; antifungal antibiotics produced by a streptomycete. Antibiot. Ann 1955/56, 576–586.

    Google Scholar 

  82. Gonzalez-Ochoa, A., L. F. Bojalil-Jaser y R. Soto Pacheco: Acciòn estimulante de las sulfonamidas–cobre y de la penicillina sobre el desarrollo de Cryptococcus neoformans y Sporotrichum schenckii, respectivamente. Rev. Soc. Mex. Hist. Nat. 11, 35–41 (1950).

    Google Scholar 

  83. Gonzalez-Ochoa, A., L. F. Bojalil-Jaber y R. Soto Pacheco: Actividades „in vitro“ de complejos sulfa-cotre sobre algunos hongos pathogénos. Rev. Inst. Salubr. Enferm. trop. (Méx.) 11, 79–91 (1950).

    CAS  Google Scholar 

  84. Gottlieb, D.: Filipin, an antibiotic inhibiting fungi. In Sternberg and Newcomer, Therapy of fungus diseases, p. 142–146. Boston and Toronto: Little, Brown & Comp. 1955.

    Google Scholar 

  85. Granits-Thurner, J., u. H. Schirmer: Über die Wirkung von Zimtsäurederivaten auf hautpathogene Pilze. Mykosen 1, 60–63 (1957).

    Google Scholar 

  86. Gridley, R. G.: A stain for fungi in tissue sections. Amer. J. clin. Path. 23, 303–307 (1953).

    CAS  Google Scholar 

  87. Grocott, R. G.: A stain for fungi in tissue sections and smears using Gomori’s methenamin-silver nitrate technic. Amer. J. clin. Path. 25, 975–979 (1955).

    CAS  Google Scholar 

  88. Grunberg, E., and R. J. Schnitzer: A chemotherapeutic study of antimonials in the experimental infection of mice with Cryptococcus neoformans. Yale J. Biol. Med. 26, 132–138 (1953).

    CAS  Google Scholar 

  89. Haskins, R. H., and J. A. Thorn: Biochemistry of the ustilaginales. Vii. Antibiotic activity of ustilagic acid. Canad. J. Bot. 29, 585–592 (1951).

    CAS  Google Scholar 

  90. Hazen, E. L., and R. Brown: Fungicidin, an antibiotic produced by a soil actinomycete. Proc. Soc. exp. Biol. (N.Y.) 76, 93–97 (1951).

    CAS  Google Scholar 

  91. Hehre, E. J., A. S Carlson, and D. M. Hamilton: Crystalline amylose from cultures of a pathogenic yeast (Torula histolytica). J. biol. Chem. 177, 289–293 (1949).

    CAS  PubMed  Google Scholar 

  92. Hickey, R. J., C. J. Corum, P. H. Hidy, J. R. Cohen, U. F. B. Nager, and E. Kropp: Ascosin, an antifungal antibiotic produced by a streptomycete. Antibiot. and Chemother. (Basel) 2, 472–483 (1952).

    CAS  Google Scholar 

  93. Hirth, L., et E. Drouret: Inhibition du virus de la mosaïque du tabac par le polyoside capsulaire de Torulopsis neoformans. Ann Inst. Pasteur 84, 437–440 (1953).

    CAS  Google Scholar 

  94. Hobby, G. L., P. P. Regna, N. Dougherty and W. E. Stieg: The antifungal activity of antibiotic XG. J. clin. Invest. 28, 927–933 (1949).

    CAS  PubMed Central  Google Scholar 

  95. Hoff, C. L.: Immunity studies of Cryptococcus hominis (Torula histolytica) in mice. J. Lab. clin. Med. 27, 751–754 (1942).

    Google Scholar 

  96. Hoffmeister, W.: Die Torulopsis neoformans-Infektion. Klin Wschr. 1951, 301–307.

    Google Scholar 

  97. Hotchkiss, R. D.: A microchemical reaction resulting in the staining of polysaccharide structures in fixed tissue preparations. Arch. Biochem. 16, 131–141 (1948).

    CAS  PubMed  Google Scholar 

  98. Johnson, C. W., J. W. Joyner and R. P. Perry: The inhibitory effect of 4 thiosemicarbazones on Cryptococcus neoformans. Antibiot. and Chemother. (Basel) 2 636–638 (1952).

    CAS  Google Scholar 

  99. Johnson, C. W., E. A., and K. L. Burdon: Eumycin - a new antibiotic active against pathogenic fungi and higher bacteria, including bacilli of tuberculosis and diphtheria. J. Bact. 51, 591 (1946).

    CAS  Google Scholar 

  100. Kaufmann, W.: Die seroiogische Differenzierung von Torulopsis neoformans und Torulopsis albida mittels der Präzipitation und Agglutination. Zbl. Bakt., II. Abt. 106, 434–437 (1944/45).

    Google Scholar 

  101. Keeney, E. L., L. Ajello and E. Lankford: Studies on common pathogenic fungi and on Actinomyces bovis. II. In vitro effect of sulfonamides. Bull. Johns Hopk. Hosp. 75, 393–409 (1944).

    Google Scholar 

  102. Kligman, A. M.: Studies of the capsular substance of Torula histolytica and the immunologic properties of Torula cells. J. Immunol. 57, 395–401 (1947).

    CAS  PubMed  Google Scholar 

  103. Kligman, A. M., and F. D. Weidman: Experimental studies on treatment of human torulosis. Arch. Derm. Syph. (Chicago) 60, 726–741 (1949).

    CAS  Google Scholar 

  104. Kligman, A. M., and E. D. DE Lamater: The immunology of the human mycoses. Ann. Rev. Microbiol. 1950, 283–312.

    Google Scholar 

  105. Kligman, A. M., H. Mescon and E. D. DE Lamater: Hotchkiss-McManus-Stain for histopathologic diagnosis of fungus diseases. Amer. J. clin. Path. 21, 86–91 (1951).

    CAS  Google Scholar 

  106. Kligman, A. M., A. P. Crane and R. F. Norris: Effect of temperature on survival of chick embryos infected intravenously with Cryptococcus neoformans (Torula histolytica). Amer. J. med. Sci. 221, 273–278 (1951).

    CAS  PubMed  Google Scholar 

  107. Kligman, A. M., and F. S. Lewis: In vitro and in vivo activity of candicidin on pathogenic fungi. Proc. Soc. exp. Biol. (N.Y.) 82, 399–404 (1953).

    CAS  Google Scholar 

  108. Koch, H.: Experimentelle Untersuchungen über den Einfluß neuerer Sulfonamide auf hautpathogene und andere Pilze. Arch. klin. exp. Derm. 205, 1–21 (1957).

    CAS  Google Scholar 

  109. Königsbauer, H.: Experimenteller Beitrag zur Behandlung der Torulose mit D 25 (2,2-Dioxy-5,5-dichlordiphenylsulfid). Zbl. Bakt., I. Abt. Orig. 164, 466–471 (1955).

    Google Scholar 

  110. Kuhn, L. R.: Growth and viability of Cryptococcus hominis at mouse and rabbit body temperatures. Proc. Soc. exp. Biol. (N.Y.) 41, 573–574 (1939).

    Google Scholar 

  111. Kuhn, L. R.: Effect of elevated body temperatures on cryptococcosis in mice. Proc. Soc. exp. Biol. (N.Y.) 71, 341–343 (1949).

    CAS  Google Scholar 

  112. Landy, M., S. B. Rosenman, and G. H. Warren: An antibiotic from Bacillus subtilis active against pathogenic fungi. J. Bact. 54, 24 (1947).

    CAS  PubMed  Google Scholar 

  113. Langeron, M.: Précis de mycologie. Paris: Marion 1945.

    Google Scholar 

  114. Larsh, H. W., ST. L. Silberg, and A. Hinton: Use of the tissue culture method in evaluating antifungal agents. Antibiot. Ann. 1956/57, 918–922.

    Google Scholar 

  115. Larsh, H. W., A. Hinton and ST. L. Silberg: The use of the tissue culture method in evaluating antifungal agents against systemic fungi. Antibiot. Ann. 1957/58, 988–991.

    Google Scholar 

  116. Littman, M. L., and L. E. Zimmerman: Cryptococcosis. New York and London: Grune & Stratton 1956.

    Google Scholar 

  117. Littman, M. L.: An improved method for detection of urea hydrolysis by fungi. J. infect. Dis. 101, 51–61 (1957).

    CAS  PubMed  Google Scholar 

  118. Littman, M. L.: Antimycotic effect of chorquinaldol. Trans. N. Y. Acad. Sci. 18, 161–177 (1955).

    CAS  PubMed  Google Scholar 

  119. Lodder, J.: Die anaskosporogenen Hefen, 1. Hälfte. Verh. Kon. Akad. Wet., Amsterdam Afd. Naturk. 32, 1–256 (1934).

    Google Scholar 

  120. Lodder, J.: Torulopsis or Cryptococcus. Mycopathologia (Den Haag) 1, 62–67 (1938).

    Google Scholar 

  121. Lodder, J., and A. DE Minjer: On the biology of the pathogenic Torulopsidoideae. In W. J. Nickerson, Biology of pathogenic fungi. Waltham, Mass.: Chronica Botanica 1947.

    Google Scholar 

  122. Lodder, J., and N. J. Kreger-Van Rij: The yeasts. A taxonomic study, 1, ed., p. 713. Amsterdam: North Holland Publ. Comp. 1952.

    Google Scholar 

  123. Ludwig, K. A., F. Y. Murray, J. K. Smith, C. R. Thompson and H. W. Werner: Laboratory studies on β-di-ethyleminoethylfencholate, a new antifungal agent. Antibiot. and Chemother. (Basel) 4, 56–61 (1954).

    CAS  Google Scholar 

  124. Mager, J., and M. Aschner: Starch reaction as aid in identification of causative agent of European Blastomycosis. Proc. Soc. exp. Biol. (N.Y.) 62, 71–72.

    Google Scholar 

  125. Mager, J., and M. Aschner: Biological studies on capsulated yeasts. J. Bact. 53, 283–295 (1947).

    CAS  PubMed  Google Scholar 

  126. McManus, J. F. A.: Histological and histochemical uses of periodic acid. Stain Technol. 23, 99–108 (1948).

    CAS  PubMed  Google Scholar 

  127. Mezey, C. M., and R. Fowler: Cerebrospinal cryptococcosis. J. Amer. med. Ass. 132, 632–634 (1946).

    CAS  Google Scholar 

  128. Miller, J M, E B. Schoenbach, P. II. Long, J. S. Schuttlework, and G. E. Snider: Treatment of infections due to Cryptococcus neoformans with stilbamidine, antibiotics and chemotherapy. Antibiot. and Chemother. (Basel) 2, 444–446 (1952).

    Google Scholar 

  129. Molnar, J.: Über die dichroitische Färbung der Kapsel des Cryptococcus neoformans Schweiz. Z. Path. 19, 82–87 (1956).

    CAS  Google Scholar 

  130. Molnar, J.: Meningo-encephalitis caused by Cryptococcus neoformans. Acta morph. Acad. Sei. hung. 6, 233–239 (1955).

    Google Scholar 

  131. Mosberg jr., W. H., and J. A. Alvarez-DE Choudens: Torulosis of the central nervous System. Lancet 1951 I, 1259–1260.

    Google Scholar 

  132. Mosberg jr., W. H., and J. C. Arnold jr.: Torulosis of the central nervous system. Ann. intern. Med. 32, 1153–1183 (1950).

    PubMed  Google Scholar 

  133. Negroni, P., y C. Briz DE Negroni: Estudios sobre el Cryptococcus neoformans (Sanfelice). II. Aspecto micromorfologico y citologia. Ann. Soc. Ci. argent. 151, 71–76 (1951).

    Google Scholar 

  134. Negroni, P., y C. A. Lanata: Estudios sobre el Cryptococcus neoformans (Sanfelice). Iii. La formation capsular. Ann. Soc. Ci. argent. 113, 200–211 (1952).

    Google Scholar 

  135. Neill, J. M., C. G. Castillo, R. H. Smith, and CH. E. Kapros: Capsular reactions and soluble antigens of Torula histolytica and of Sporotrichum schenckii. J. exp. Med. 89, 93–106 (1949).

    CAS  PubMed Central  PubMed  Google Scholar 

  136. Neill, J. M., and CH. E. Kapros: Serological tests on soluble antigens from mice infected with Cryptococcus neoformans and Sporotrichum schenckii. Proc. Soc. exp. Biol. (N. Y.) 73, 557–559 (1950).

    CAS  Google Scholar 

  137. Neill, J. M., I. Abrahams, and CH. E. Kapros: A comparison of the immunogenicity of weekly encpasulated and strongly encapsulated strains of Cryptococcus neoformans. J. Bact. 59, 263–275 (1950).

    CAS  PubMed  Google Scholar 

  138. Neill, J. M., J. V. SuGG and D. W. McCauley: Serologically reactive material in spinal fluid, blood and urine from a human case of cryptococcosis (torulosis). Proc. Soc. exp. Biol. (N. Y.) 77, 775–778 (1951).

    CAS  Google Scholar 

  139. Nickerson, W. J.: Studies on film forming yeasts. Mycologia (N. Y.) 36, 224–233 (1944).

    Google Scholar 

  140. Nino, F. A.: Contribución al estudio de las blastomicosis en la republica argentina: Cap. V. Granuloma criptococcico. Bol. Inst. Clin. quir. Univ. B. Aires 14, 656–755 (1938).

    Google Scholar 

  141. Petru, M., u. M. Vojtéchovseal: Zur Frage der sog. Vaginal-Kryptokokken. Zbl. Bakt. I. Abt. Orig. 166, 218–224 (1956).

    CAS  Google Scholar 

  142. Pounder, W. D., J. M. Amberson and R. F. Jaeger: A severe mastitis problem associated with Cryptococcus neoformans in a large dairy herd. Amer. J. vet. Res. 13, 121–128 (1957).

    Google Scholar 

  143. Raper, K. B., and D. F. Alexander: Preservation of molds by the lyophil process. Micologia (N. Y.) 37, 499–525 (1945).

    Google Scholar 

  144. Rappaport, B. Z., and B. Kaplan: Generalized Torula mycosis. Arch. Path. (Chicago) 1, 720–741 (1926).

    Google Scholar 

  145. Ratcliffe, H. E., and W. R. Cook: Cryptococcosis; review of the literature and report of a case with initial pulmonary findings. U.S. armed Forces med. J. 1, 957–969 (1950).

    CAS  PubMed  Google Scholar 

  146. Redaelli, P.: Il problema della Torulopsidaceae e dei loro rapporti con l’uomo e con la pathologica umana studiato particolarmente in Italia. Vi. biol. 13, 171–235 (1931)

    Google Scholar 

  147. Redaelli, P., R. Ciferri e A. Giordano: Debaryomyces neoformans (Sanfelice) nobis, n. comb., pour les espèces de la groupe Saccharomyces hominis — Cryptococcus neoformans — Torula histolytica. Soz. internaz. Microbiol. Boll. sez. ital. 9, 24–28 (1937).

    Google Scholar 

  148. Reid, J. D.: The influence of Vitamin B complex on the growth of Torulopsis (Cryptococcus) neoformans on a synthetic medium. J. Bact. 58, 777–782 (1949).

    CAS  PubMed  Google Scholar 

  149. Reilly, H. C., A. Schatz and S. A. Waksman: Antifungal properties of antibiotic substances. J. Bact. 49, 585–594 (1945).

    CAS  PubMed  Google Scholar 

  150. Ribi, E., S. B. Salvin and W. R. Brown: Antigens from the yeast phase of Histoplasma capsulatum. I. Morphology of the cell as revealed by the electron microscope. Exp. Cell Res. 10, 394–404 (1956).

    CAS  PubMed  Google Scholar 

  151. Rinehart, J. F., and S. K. Abdul-Haj: An improved method for histologic demonstration of acid mucopolysaccharides. Arch. Path. (Chicago) 52, 189–194 (1951).

    CAS  Google Scholar 

  152. Roberts, C.: Observations on the yeast Lipomyces. Nature (Lond.) 179, 1198–1199 (1957).

    CAS  Google Scholar 

  153. Salvin, S. B.: Quantitative studies as the serologic relationships of fungi. J. Immunol. 65, 617–626 (1950).

    CAS  PubMed  Google Scholar 

  154. Salvin, S. B.: Endotoxins in pathogenic fungi. J. Immunol. 69, 89–99 (1952).

    CAS  PubMed  Google Scholar 

  155. Sanfelice, F.: Über eine für Tiere pathogene SproBpilzart und über die morphologische Übereinstimmung, welche sie bei ihrem Vorkommen in den Geweben mit den vermeintlichen Krebscoccidien zeigt. Zbl. Bakt., I. Abt. Orig. 17, 113–118 (1895).

    Google Scholar 

  156. Sanfelice, F.: Über einen neuen pathogenen Blastomyceten, welcher innerhalb der Gewebe unter Bildung kalkartig aussehender Massen degeneriert. Zbl. Bakt., I. Abt. Orig. 18, 521–526 (1895).

    Google Scholar 

  157. Sanfelice, F.: Sulla azione patogena dei blastomiceti. Ann. Ist. Ig. Univ. Roma 5, 239–262 (1895).

    Google Scholar 

  158. Sasakawa, M.: Zur Systematik pathogener und parasitischer Hefen. Morphologisch-biochemische Studie. Zbl. Bakt., I. Orig. 88, 269–285 (1922).

    Google Scholar 

  159. Scherr, G. H., and R. H. Weaver: The dimorphism phenomenon in yeasts. Bact. Rev. 17, 51–92 (1933).

    Google Scholar 

  160. Schmidt, E. G., J. A. Alvarez-Dechoudens, N. F. McElvain, J. Beardsley and S. A. A. Tawab: A microbiological study of Cryptococcus neoformans. Arch. Biochem. 26, 15–24 (1950).

    CAS  Google Scholar 

  161. Schmidt, W. J.: Dichroitische Färbung tierischer und pflanzlicher Gewebe. In Handbuch der biologischen Arbeitsmethoden, Abt. V, 2/2, S. 1835. Wien: Urban & Schwarzenberg 1932.

    Google Scholar 

  162. Seeliger, H. P. R.: Experimentelle Untersuchungen zur mykologischen Serodiagnostik. Habil.-Schrift Bonn 1954.

    Google Scholar 

  163. Seeliger, H. P. R.: Zur Anwendungsmöglichkeit der Präzipitation im Agar-Gel bei der 0-Antigenanalyse von Bakterien und Pilzen. Z. Hyg. Infekt.-Kr. 141, 110–121 (1955).

    CAS  Google Scholar 

  164. Seeliger, H. P. R.: Ein neues Medium zur Pseudomyzelbildung von Candida albicans. Z. Hyg. Infekt.-Kr. 141, 488–494 (1955).

    CAS  Google Scholar 

  165. Seeliger, H. P. R.: Lungenmykosen und ihre Immunbiologie. Med. Wschr. 1954, 692–698.

    Google Scholar 

  166. Seeliger, H. P. R.: Mykologie und Serologie der Pneumomykosen. Tuberk.-Arzt 9, 451–463 (1955).

    CAS  Google Scholar 

  167. Seeliger, H. P. R.: Use of a urease test for the screening and identification of Cryptococci. J. Bact. 72, 127–131 (1956).

    CAS  PubMed  Google Scholar 

  168. Seeliger, H. P. R.: Pilzbefall und Mykosen des Menschen. Röntgen-u. Lab.-Prax. 9, 192–203, 221–233 (1956).

    Google Scholar 

  169. Seeliger, H. P. R.: Mykologische Serodiagnostik. Leipzig: Johann Ambrosius Barth 1958.

    Google Scholar 

  170. Seeliger, H. P. R., u. P. Crist: Zur Schnelldiagnose der Cryptococcus-Meningitis mittels der Liquorpräzipitation. Mykosen 1, 88–92 (1958).

    Google Scholar 

  171. Seeliger, H. P. R.: Über die pilzhemmende Wirkung eines neuen Benzimidazolderivats. Mykosen 1, 162–171 (1958).

    Google Scholar 

  172. Seeliger, H. P. R.: Cryptococcose (Torulose). Mitt. der Schering-Werke 19 (1958).

    Google Scholar 

  173. Seeliger, H. P. R.: Unveröffentlichte Untersuchungen, 1953–1957.

    Google Scholar 

  174. Segretanv, G., et E. Drouhet: L’action de la streptomycine sur Torulopsis histolytica (T. neoformans) in vitro et in vivo. C. R. Soc. Biol. (Paris) 142, 319–320 (1948).

    Google Scholar 

  175. Segretanv, G., E. Drouhet, et F. Mariat: Essai de mise en évidence à l’état frais de la capsule d’une levure pathogène. Bull. Microscop. appl., Sér. II 2, 17–18 (1952).

    Google Scholar 

  176. Seneca, H., J. H. Kane and J. Rockenbach: Bactericidal, protozoicidal and fungicidal properties of thiolutin. Antibiot. and Chemother. (Basel) 2, 357–360 (1952).

    CAS  Google Scholar 

  177. Sheppe, W. M.: Torula infection in man. Amer. J. med. Sci. 167, 91–108 (1924).

    Google Scholar 

  178. Shimwell, J. L.: A simple staining method for the detection of askospores in yeasts. J. Inst. Brewing 35, 474 (1938).

    Google Scholar 

  179. Siegel, M.: Fungistatic activity of methylparaben and propylparaben. Antibiot. and Chemother. (Basel) 3, 478–480 (1953).

    CAS  Google Scholar 

  180. Simon, J.: In vitro inhibition of mixed strains of Cryptococcus neoformans isolated from cattle. Amer. J. vet. Res. 16, 394–396 (1955).

    CAS  PubMed  Google Scholar 

  181. Skinner, CH. E., CH. W. Emmons and A. M. Tsuchiya: In Henrici’s molds, yeasts and (actinomycetes, 2. edit. New York and London: John Wiley & Sons 1947.

    Google Scholar 

  182. Skinner, CH. E., CH. W. Emmons and A. M. Tsuchiya: Generic name for imperfect yeasts, Cryptococcus and Torulopsis. Amer. Midld. Naturalist 43, 242–250 (1950).

    Google Scholar 

  183. Solotorovsky, M. H., E. J. Ironson, F. J. Gregory and S. Winsten: Activity of certain diamidines against blastomycosis and Candida infections in mice. Antibiot. and Chemother. (Basel) 4, 165–168 (1954).

    CAS  Google Scholar 

  184. Stanley, N. F.: Polysaccharide haptens from Torula histolytica. Amer. J. exp. Biol. Med. Sci. 27, 409–415 (1949).

    CAS  Google Scholar 

  185. Steward, R. A., and K. F. Meyer: Isolation of C immitis (Stiles) from soil. Proc. Soc. exp. Biol. (N. Y.) 29, 937–938 (1932). Zit. nach Emmons (60).

    Google Scholar 

  186. Stoddard, J. L., and E. C. Cutler: Torula infection in man Monogr. Rockefeller Inst. med. Res. No 6 (1916), 98 S.

    Google Scholar 

  187. Symmers, W. F.: Torulosis. Lancet 1953 II, 1068–1074.

    Google Scholar 

  188. Tager, M., and T. S. Danowski: Inhibition of the growth of fungi by thiourea derivatives, particularly hydrazine dithiocarbamyl. J. infect. Dis. 82, 126–130 (1948).

    CAS  PubMed  Google Scholar 

  189. Tager, M., A. B. Hales and T. S. Danowsxi: Studies on the suppression of fungus growth by thiourea. Iii. The effects of protein fractions, amino acids and thiol compounds. J. infect. Dis. 84, 284–289 (1949).

    CAS  PubMed  Google Scholar 

  190. Thayer, J. D., W. Arson and A. J. Walker: The in vitro and in vivo effect of circulin on Cryptococcus neoformans. J. Bact. 62, 112 (1951).

    Google Scholar 

  191. Todd, R. L., and W. W. Hermann: The life cycle of the organism causing yeast-meningitis. J. Bact. 32, 89–102 (1936).

    CAS  PubMed  Google Scholar 

  192. Tomcsik, J., and S. Guex-Holzer: Demonstration of the bacterial capsule by means of a pH-dependant salt-like combination with protein. J. gen. Microbiol. 10, 97–109 (1954).

    CAS  PubMed  Google Scholar 

  193. Uzman, L. L., H. RosEN and G. E. Foley: Studies on the biology of Cryptococcus. VI. Amino acid composition of the somatic proteins of Cryptococcus neoformans. J. infect. Diss. 98, 208–210 (1956).

    CAS  Google Scholar 

  194. Vanbreuseghem, R.: Torulosis et Torulopsis neoformans. Ann. Soc. belge Méd. trop. 23, 495–501 (1953).

    Google Scholar 

  195. Verdun, P.: Précis de parasitologie humaine, parasites animaux et végétaux, les bactéries exceptées. 2. edit. Paris: V. Doin 1912.

    Google Scholar 

  196. Vuillemin, P.: Les blastomycètes pathogènes. Rev. gén. Sci 12, 732–751 (1901).

    Google Scholar 

  197. Waksman, S. A.: Outstanding problems in the study of antibacterial and antifungal antibiotics (with special reference to the antibiotics or actinomycetes). In Sternberg and Newcomer, Therapy of fungus diseases, p. 3–12. Boston and Toronto: Little, Brown & Comp. 1955.

    Google Scholar 

  198. Walton, R. B., and H. B. Woodruff: A crystalline antifungal agent, mycosubtilin, isolated from Subtilis broth. J. clin. Invest. 28, 924–926 (1949).

    CAS  PubMed Central  PubMed  Google Scholar 

  199. Weiss, J. D.: Four pathogenic Torulae (blastomycetes). J. med. Res. 2, 280–311 (1902).

    Google Scholar 

  200. Whiffen, A. J., N. BonoNos and R. L. Emerson: The production of an antifungal antibiotic by Streptomyces griseus. J. Bact. 52, 610–611 (1946).

    CAS  PubMed  Google Scholar 

  201. Wickerham, L. J.: A critical evaluation of the nitrogen assimilation tests commonly used in the classification of yeasts. J. Bact. 52, 293–301 (1946).

    CAS  Google Scholar 

  202. Wickerham, L. J., and K. A. Burton: Carbon assimilation tests for the classification of yeasts. J. Bact. 56, 363–371 (1948).

    CAS  PubMed  Google Scholar 

  203. Wickerham, L. J., and M. H. Flickinger: Viability of yeasts preserved two years by the lyophil process. Brewers Digest 21, No 4 (1946).

    Google Scholar 

  204. Wickerham, L. J.: Recent advances in the taxonomy of yeasts. Ann. Rev. Microbiol. 6, 317–332 (1952).

    CAS  Google Scholar 

  205. Wilson, H. M., and A. W. Duryea: Cryptococcus meningitis (Torulosis) treated with a new antibiotic, actidione. Arch. Neurol. Psychiat. (Chicago) 66, 470–480 (1951).

    CAS  Google Scholar 

  206. Wolf, F. T.: Inhibition of pathogenic fungi by p-hydroxymethylbenzoate. Mycopathologia (Den Haag) 5, 117–119 (1950).

    CAS  Google Scholar 

  207. Wolfram, ST., u. F. Zach: Über durch niedere Pilze verursachte Nagelerkrankungen beim Menschen. Arch. Derm. Syph. (Berl.) 170, 681–694 (1934).

    Google Scholar 

  208. Beutmann, W.: Immunbiologische und serologische Studien an Hefen. Arch. Mikrobiol 29, 227–256 (1958).

    CAS  PubMed  Google Scholar 

  209. Burcik, E., u. W. Beutmann: Zuckerbausteine wasserlöslicher Hefepolysaccharide von Haptencharakter. Naturwiss. 43, 427–428 (1956).

    CAS  Google Scholar 

  210. Eveland, W. C., J. D. Marshall and A. M. Silverstein: Rapid identification of pathogenic microorganisms using fluorescent antibodies of contrasting colors. Abstracts of communications, 7. Internat. Congr. for Microbiology, Stockholm, S. 313. 1958.

    Google Scholar 

  211. Holtz: Briefl. Mitt., Juli 1958.

    Google Scholar 

  212. Klatzo, I., and P. H. Geisler: Demonstration of Cryptococcus neoformans in polarized light. Stain Technol. 33, 55–56 (1958).

    CAS  PubMed  Google Scholar 

  213. Staib, F.: Resistenz on Hefen und hefeartigen Pilzen gegen Schwefelsäure. Z. Hyg. Infekt.-Kr. 145, 26–33 (1958).

    CAS  Google Scholar 

Download references

Authors
  1. H. P. R. Seeliger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Düsseldorf, Deutschland

    W. Kikuth

  2. San Francisco, USA

    K. F. Meyer

  3. Hamburg, Deutschland

    E. G. Nauck

  4. Cambridge, Mass., USA

    A. M. Pappenheimer Jr.

  5. Basel, Schweiz

    J. Tomcsik

Rights and permissions

Reprints and permissions

Copyright information

© 1959 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Seeliger, H.P.R. (1959). Das kulturell-biochemische und serologische Verhalten der Cryptococcus-Gruppe. In: Kikuth, W., Meyer, K.F., Nauck, E.G., Pappenheimer, A.M., Tomcsik, J. (eds) Ergebnisse der Mikrobiologie Immunitätsforschung und Experimentellen Therapie. Current Topics in Microbiology and Immunology, vol 32. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-42618-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-42618-0_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-02385-2

  • Online ISBN: 978-3-662-42618-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation